amygdalin has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, K; Li, H; Li, Q; Lin, S; Liu, R; Liu, Z; Wang, T; Xu, H | 1 |
| Lv, J; Pan, W; Wu, H; Zhang, A | 1 |
2 other study(ies) available for amygdalin and Lung Injury, Acute
| Article | Year |
|---|---|
A stepwise integrated multi-system to screen quality markers of Chinese classic prescription Qingzao Jiufei decoction on the treatment of acute lung injury by combining 'network pharmacology-metabolomics-PK/PD modeling'.
Topics: Acute Lung Injury; Administration, Oral; Amygdalin; Animals; Biological Availability; Biomarkers, Pharmacological; Chalcone; Chlorogenic Acid; Dioxoles; Drugs, Chinese Herbal; Flavanones; Glucosides; Lignans; Male; Metabolomics; Rats, Wistar; Triterpenes; Ursolic Acid | 2020 |
Protective Effect of Amygdalin on LPS-Induced Acute Lung Injury by Inhibiting NF-κB and NLRP3 Signaling Pathways.
Topics: Acute Lung Injury; Amygdalin; Animals; Antineoplastic Agents, Phytogenic; Lipopolysaccharides; Mice; NF-kappa B; Receptors, Cell Surface; Signal Transduction | 2017 |